Article

Association of ALDH1A1 Polymorphism With Toxicity From Cyclophosphamide Treatment

2022-02-08

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose: </bold>Cyclophosphamide is a commonly used cancer agent that is metabolically activated by polymorphic enzymes. This study aims to investigate the association between genetic polymorphisms of candidate pharmacogenes with severe toxicity during cyclophosphamide treatment.<bold>Methods: </bold>Genetic data was collected from an institutional genetic data repository. Genetic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2677502-89b5-5f79-9da9-51d482dd17af
DOI: 10.21203/rs.3.rs-1228933/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of ALDH1A1 Polymorphism With Toxicity From Cyclophosphamide TreatmentDOI 10.21203/rs.3.rs-1228933/v1Read

Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer.Semantic proximity Read

Influence of Genetic Variation of GST, CYP, and ABC on the Safety and Efficacy of Cyclophosphamide-Based Therapy.Semantic proximity Read

Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.Semantic proximity Read

The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomesSemantic proximity Read

Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastomaSemantic proximity Read

Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) RegimenSemantic proximity Read

[SNPs associated with adverse effects].Semantic proximity Read

Cyclophosphamide pharmacogenomics and their effect on its bioactivation and pharmacokineticsSemantic proximity Read

Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients.Semantic proximity Read

Contributing factors on metabolic mechanism-based CYP3A4-activated/deactivated anticancer drugs: implications for individualizing chemotherapySemantic proximity Read

Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.Semantic proximity Read

Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients.Semantic proximity Read